Terns Pharmaceuticals Stock Analysis

Terns Stock Analysis Notes

About 100.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Terns Pharmaceuticals recorded a loss per share of 1.08. The entity had not issued any dividends in recent years. The firm had 1000:50 split on the 4th of November 2013. Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and obesity. The company was incorporated in 2016 and is headquartered in Foster City, California. Terns Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. To find out more about Terns Pharmaceuticals contact Senthil Sundaram at 650 525 5535 or learn more at https://www.ternspharma.com.

Terns Pharmaceuticals Investment Alerts

Terns Pharmaceuticals Upcoming and Recent Events

Terns Largest EPS Surprises

View All Earnings Estimates

Terns Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Terns Pharmaceuticals Thematic Classifications

Terns Stock Institutional Investors

Note, although Terns Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Terns Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 492.59 M.

Terns Profitablity

Management Efficiency

Terns Pharmaceuticals has return on total asset (ROA) of (0.2215) % which means that it has lost $0.2215 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3212) %, meaning that it created substantial loss on money invested by shareholders. Terns Pharmaceuticals' management efficiency ratios could be used to measure how well Terns Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of July 2025, Return On Tangible Assets is likely to drop to -0.26. In addition to that, Return On Capital Employed is likely to drop to -0.31. As of the 20th of July 2025, Net Tangible Assets is likely to grow to about 334.4 M, while Total Assets are likely to drop about 203.2 M.

Technical Drivers

As of the 20th of July, Terns Pharmaceuticals has the Risk Adjusted Performance of 0.2961, coefficient of variation of 324.27, and Semi Deviation of 3.02. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Terns Pharmaceuticals, as well as the relationship between them.

Terns Pharmaceuticals Price Movement Analysis

Terns Pharmaceuticals Insider Trading Activities

Terns Pharmaceuticals Outstanding Bonds

Terns Pharmaceuticals Predictive Daily Indicators

Terns Pharmaceuticals Corporate Filings

Terns Pharmaceuticals Forecast Models

Terns Pharmaceuticals' time-series forecasting models are one of many Terns Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Terns Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Terns Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Terns shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Terns Pharmaceuticals. By using and applying Terns Stock analysis, traders can create a robust methodology for identifying Terns entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Terns analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Terns analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Terns Pharmaceuticals stock analysis indicators help investors evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By understating and applying Terns Pharmaceuticals stock analysis, traders can identify Terns Pharmaceuticals position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Terns Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.